Additionally, CLDN6 can interact with proteins containing PDZ domains or PDZ–binding motifs (PBMs) such as ZO–1, AF–6, and β–catenin through its PBM, which made CLDN6 communicate with proteins or pathways to play important roles in breast cancers [8,9,10]. The gene discussed is CLDN6; the disease is breast cancer.